Human Papillomavirus DNA Tests
"Human Papillomavirus DNA Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods for detecting or typing the DNA of an ALPHAPAPILLOMAVIRUS in biological tissues and fluids.
| Descriptor ID |
D061809
|
| MeSH Number(s) |
E01.370.225.880.500 E05.200.880.500 E05.393.520.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Human Papillomavirus DNA Tests".
Below are MeSH descriptors whose meaning is more specific than "Human Papillomavirus DNA Tests".
This graph shows the total number of publications written about "Human Papillomavirus DNA Tests" by people in this website by year, and whether "Human Papillomavirus DNA Tests" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 3 | 3 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 2 | 3 |
| 2016 | 0 | 2 | 2 |
| 2017 | 2 | 1 | 3 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Human Papillomavirus DNA Tests" by people in Profiles.
-
HPV status in women with high-grade dysplasia on cervical biopsy and preceding negative HPV tests. J Am Soc Cytopathol. 2019 May - Jun; 8(3):149-156.
-
High grade squamous intraepithelial lesion on high-risk HPV negative patients: Why we still need the Pap test. Diagn Cytopathol. 2018 Nov; 46(11):908-913.
-
Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer. Cancer Cytopathol. 2017 Aug; 125(8):652-657.
-
Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening. Cancer Cytopathol. 2017 Aug; 125(8):644-651.
-
Next generation sequencing and its applications in HPV-associated cancers. Oncotarget. 2017 Jan 31; 8(5):8877-8889.
-
Human Papillomavirus Drives Tumor Development Throughout the Head and Neck: Improved Prognosis Is Associated With an Immune Response Largely Restricted to the Oropharynx. J Clin Oncol. 2016 12; 34(34):4132-4141.
-
Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes. Head Neck. 2016 09; 38(9):1330-7.
-
Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab. J Clin Oncol. 2016 Apr 20; 34(12):1300-8.
-
Multiple Human Papilloma Virus Infections and Their Impact on the Development of High-Risk Cervical Lesions. Acta Cytol. 2015; 59(5):391-8.
-
Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma. JAMA Oncol. 2015 Oct; 1(7):907-15.